2023 was a big year for CRISPR-based gene editing but cha...

avatar

Gadgets

🔈⌨️📱📸💻🎮🖥️📹🖱️🕹️

Engadget's profile picture on Select App
En

Engadget

·3 years ago
shared a link post in group #Gadgets
2023 was a big year for CRISPR-based gene editing but challenges remain
www.engadget.com

2023 was a big year for CRISPR-based gene editing but challenges remain

2023 was an important year for patients with sickle cell disease. The FDA approved Vertex’s “Casgevy,” a CRISPR-based therapy for the treatment of sickle cell disease marking it as the first genetical

Comment here to discuss with all recipients or tap a user's profile image to discuss privately.

Embed post to a webpage :
<div data-postid="enwkpme" [...] </div>
Powered bySelect·iOS·Android
Privacy|Terms|